BRAFV600EandNRASQ61L/Q61Rmutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting-Reference-Cited by-同舟云学术

BRAFV600EandNRASQ61L/Q61Rmutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting

Published:2016-06-15 Issue:4 Volume:69 Page:680-686
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Kakavand Hojabr¹²,Walker Emily²³,Lum Trina³,Wilmott James S¹²,Selinger Christina I³,Smith Elizabeth¹²,Saw Robyn P M¹²,Yu Bing²⁴,Cooper Wendy A²³,Long Georgina V¹²⁵,O'Toole Sandra A²³,Scolyer Richard A¹²³

Affiliation:

1. Melanoma Institute Australia; North Sydney NSW Australia

2. Sydney Medical School; The University of Sydney; Camperdown NSW Australia

3. Tissue Pathology and Diagnostic Oncology; Royal Prince Alfred Hospital; Camperdown NSW Australia

4. Medical Genomics; Royal Prince Alfred Hospital; Camperdown NSW Australia

5. Melanoma Oncology; Royal North Shore and Mater Hospital; Sydney NSW Australia

Funder

National Health and Medical Research Council

Cancer Institute New South Wales

Melanoma Institute Australia

Australian Postgraduate Awards (APA)

Publisher